Stay updated on Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page
- Check4 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide NIH banner announces transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check18 days agoChange DetectedThe footer's site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1. The page continues to show a 403 error instead of the study record.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study record details with basic site chrome; the full study record content (title, sponsor, documents, and locations) has been removed from the page.SummaryDifference17%

- Check67 days agoChange DetectedThe page now includes an NIH grant/contract note under Other Study ID Numbers and the site revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.0%

Stay in the know with updates to Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.